Skip to main content

CLN2 Disease News

Related terms: Classic Late Infantile Neuronal Ceroid Lipofuscinosis, Neuronal Ceroid Lipofuscinosis Type 2, Late-Infantile Batten Disease

FDA Approves Brineura (cerliponase alfa) for CLN2 Disease, a Form of Batten Disease

April 27, 2017 – The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment...

Ask a question

To post your own question to this support group, sign in or create an account.